Suppressive efficacy and proliferative capacity of human regulatory t cells in allogeneic and xenogeneic responses

Transplantation

Volumn 86, Issue 10, 2008, Pages 1452-1462

  Lin, Yih Jyh ^a,b,c   Hara, Hidetaka ^a   Tai, Hao Chih ^a   Long, Cassandra ^a   Tokita, Daisuke ^a   Yeh, Peter ^a   Ayares, David ^d   Morelli, Adrian E ^a   Cooper, David K C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^d REVIVICOR INC   (United States)

Author keywords

Human; Mixed lymphocyte reaction; Pig; Regulatory T cells; Xenotransplantation.

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; TRANSCRIPTION FACTOR FOXP3; GALACTOSYLTRANSFERASE; INTERLEUKIN 2 RECEPTOR ALPHA; LEUKOCYTE ANTIGEN;

ALLOIMMUNITY; ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SWINE; UPREGULATION; XENOTRANSPLANTATION; ALLOTRANSPLANTATION; ANIMAL; GENETICS; GRAFT REJECTION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; TRANSGENIC ANIMAL; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; GALACTOSYLTRANSFERASES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; SWINE; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 58149330240     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318188acb0     Document Type: Article

References (68)

1. Cooper DK. Clinical xenotransplantion - How close are we? Lancet 2003; 362: 557.
2. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3galactosyltransferase-deficient pigs. Science 2003; 299: 411.
3. Kolber-Simonds D, Lai L, Watt SR, et al. Production of alpha-1,3 galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 2004; 101: 7335.
4. Buhler LH, Cooper DK. How strong is the T cell response in the pigto-primate model? Xenotransplantation 2005; 12: 85.
5. Auchincloss H Jr. Cell-mediated xenoresponses: Strong or weak? Clin Transplant 1994; 8 (2 Pt 2): 155.
6. Auchincloss H Jr, Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433.
7. Yamada K, Sachs DH, DerSimonian H. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 1995; 155: 5249.
8. Platt JL. Immunobiology of xenotransplantation. Transpl Int 2000; 13(suppl 1): S7.
9. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
10. Waldmann H, Graca L, Cobbold S, et al. Regulatory T cells and organ transplantation. Semin Immunol 2004; 16: 119.
11. Porter CM, Bloom ET. Human CD4+CD25+ regulatory T cells sup- press anti-porcine xenogeneic responses. Am J Transplant 2005; 5: 2052.
12. Wells AD, Gudmundsdottir H, Turka LA. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 1997; 100: 3173.
13. Nitta Y, Nelson K, Andrews RG, et al. CFSE dye dilution mixed lymphocyte reactions quantify donor-specific alloreactive precursors in non-human primate cardiac graft rejection. Transplant Proc 2001; 33: 326.
14. Tokita D, Ohdan H, Onoe T, et al. Liver sinusoidal endothelial cells contribute to alloreactive T-cell tolerance induced by portal venous injection of donor splenocytes. Transpl Int 2005; 18: 237.
15. Shevach EM, McHugh RS, Piccirillo CA, et al. Control of T-cell activation by CD4+ CD25+ suppressor T cells. ImmunolRev 2001; 182:58.
16. Buckner JH, Ziegler SF. Regulating the immune system: The induction of regulatory T cells in the periphery. Arthritis Res Ther 2004; 6: 215.
17. Jiang S, Lechler RI, He XS, et al. Regulatory T cells and transplantation tolerance. Hum Immunol 2006; 67: 765.
18. Aluvihare VR, Betz AG. The role of regulatory T cells in alloantigen tolerance. Immunol Rev 2006; 212: 330.
19. Franzke A, Hunger JK, Dittmar KE, et al. Regulatory T-cells in the control of immunological diseases. Ann Hematol 2006; 85: 747.
20. Ziegler SF. FOXP3: Ofmice and men. Annu Rev Immunol2006; 24:209.
21. Baecher-Allan C, Brown JA, Freeman GJ, et al. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245.
22. Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20.
23. Walker MR, Kasprowicz DJ, Gersuk VH, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J Clin Invest 2003; 112: 1437.
24. Morgan ME, van Bilsen JH, Bakker AM, et al. Expression of FOXP3 mRNA is not confined to CD4+CD25 + T regulatory cells in humans. Hum Immunol 2005; 66: 13.
25. Allan SE, Passerini L, Bacchetta R, et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.JClin Invest 2005; 115:3276.
26. Longhi MS, Hussain MJ, Mitry RR, et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006; 176: 4484.
27. Li S, Jones KL, Woollard DJ, et al. Defining target antigens for CD25 + FOXP3 + IFN-gamma- regulatory T cells in chronic hepatitis C virus infection. Immunol Cell Biol 2007; 85: 197.
28. Tseng YL, KuwakiK, DorFJ, etal. alpha1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 2005; 80: 1493.
29. Dorling A. Clinical xenotransplantation: Pigs might fly? Am J Transplant 2002; 2: 695.
30. Kirk AD, Li RA, Kinch MS, et al. The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness. Transplantation 1993; 55: 924.
31. Li T, Li YP, Yang ZM. [Direct and indirect recognition in pig-to-man xenotransplantation]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 1999; 13: 373.
32. Dorling A, Lombardi G, Binns R, et al. Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population. Eur J Immunol 1996; 26: 1378.
33. Dorling A, Lechler RI. T cell-mediated xenograft rejection: Specific tolerance is probably required for long term xenograft survival. Xenotransplantation 1998; 5: 234.
34. Bonenfant C, Vallee I, Sun J, et al. Analysis of human CD4 T lymphocyte proliferation induced by porcine lymphoblastoid B cell lines. Xenotransplantation 2003; 10: 107.
35. Bravery CA, Batten P, Yacoub MH, et al. Direct recognition of SLA-and HLA-like class II antigens on porcine endothelium by human T cells results in T cell activation and release of interleukin-2. Transplantation 1995; 60: 1024.
36. Dorling A, Binns R, Lechler RI. Significant primary indirect human T-cell anti-pig xenoresponses observed using immature porcine dendritic cells and SLA-class II-negative endothelial cells. Transplant Proc 1996; 28: 654.
37. Vallee I, Guillaumin JM, Thibault G, et al. Human T lymphocyte proliferative response to resting porcine endothelial cells results from an HLA-restricted, IL-10-sensitive, indirect presentation pathway but also depends on endothelial-specific costimulatory factors. J Immunol 1998; 161: 1652.
38. Jiang S, Herrera O, Lechler RI. New spectrum of allorecognition pathways: Implications for graft rejection and transplantation tolerance. Curr Opin Immunol 2004; 16: 550.
39. Murray AG, Khodadoust MM, Pober JS, et al. Porcine aortic endothelial cells activate human T cells: Direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1: 57.
40. Rollins SA, Kennedy SP, Chodera AJ, et al. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2. Transplantation 1994; 57: 1709.
41. Charreau B, Coupel S, Boulday G, et al. Cyclosporine inhibits class II major histocompatibility antigen presentation by xenogeneic endothelial cells to human T lymphocytes by altering expression of the class II transcriptional activator gene. Transplantation 2000; 70: 354.
42. Hartig CV, Haller GW, Sachs DH, et al. Naturally developing memory T cell xenoreactivity to swine antigens in human peripheral blood lymphocytes. J Immunol 2000; 164:2790.
43. Li Y, LiT, BuH, etal. Xenoantigenacity of Chinese Neijiang pig-related to xenotransplantation. Transplant Proc 2000; 32: 875.
44. Xu XC, Goodman J, Sasaki H, et al. Activation of natural killer cells and macrophages by porcine endothelial cells augments specific T-cell xenoresponse. Am J Transplant 2002; 2: 314.
45. Saethre M, Schneider MK, Lambris JD, et al. Cytokine secretion depends on Galalpha(1,3)Gal expression in a pig-to-human whole blood model. J Immunol 2008; 180: 6346.
46. Gudmundsdottir H, Wells AD, Turka LA. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: Effector function is linked to proliferative capacity. J Immunol 1999; 162: 5212.
47. Suchin EJ, Langmuir PB, Palmer E, et al. Quantifying the frequency of alloreactive T cells in vivo: New answers to an old question. J Immunol 2001; 166: 973.
48. Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 2000; 243: 147.
49. Tokita D, Shishida M, Ohdan H, et al. Liver sinusoidal endothelial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity. J Immunol 2006; 177:3615.
50. Cunningham AC, Butler TJ, Kirby JA. Demonstration of direct xenorecognition of porcine cells by human cytotoxic T lymphocytes. Immunology 1994; 81: 268.
51. Alam SM, Travers PJ, Wung JL, et al. T-cell-receptor affinity and thymocyte positive selection. Nature 1996; 381: 616.
52. Taylor PA, Noelle RJ, Blazar BR. CD4( + )CD25( + ) immune regula- tory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 1311.
53. Gregori S, Casorati M, Amuchastegui S, et al. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167:1945.
54. Sanchez-Fueyo A, Weber M, Domenig C, et al. Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol 2002; 168: 2274.
55. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641.
56. Zheng XX, Sanchez-Fueyo A, Sho M, et al. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 2003; 19: 503.
57. Ochando JC, Homma C, Yang Y, et al. Alloantigen-presenting plasma-cytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 2006; 7: 652.
58. Hara M, Kingsley CI, Niimi M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789.
59. Quezada SA, Fuller B, Jarvinen LZ, et al. Mechanisms of donor-specific transfusion tolerance: Preemptive induction of clonal T-cell exhaustion via indirect presentation. Blood 2003; 102: 1920.
60. Shevach EM. CD4+ CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol 2002; 2: 389.
61. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005; 6: 331.
62. Banham AH. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Trends Immunol 2006; 27: 541.
63. Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203: 1701.
64. Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203: 1693.
65. Bacchetta R, Passerini L, Gambineri E, et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006; 116: 1713.
66. Gavin MA, Torgerson TR, Houston E, et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006; 103:6659.
67. Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007; 445: 766.
68. Curiel TJ. Regulatory T-cell development: Is Foxp3 the decider? Nat Med 2007; 13: 250.